Oxford Brain Diagnostics Ltd

🇬🇧 🇮🇹 We are very excited to share yet another paper this month. CDM demonstrates clinical utility with Mild Cognitively Impaired subjects who are #Amyloid and #Tau negative. A challenge for every #neurologist around the world who wants to understand more on differential diagnosis. Our results, once again, show that #microstructure as a measure #neurodegeneration early in disease stage can play a vital role to support clincial decision making. Link below to our website to access the paper. https://lnkd.in/gDAP56w4 #dementia #alzheimersdisease #cortex #AAIC2024 #patientcare

Alzheimer's Association® International Conference is just around the corner. We cannot wait! Dr Steven Chance, Omar Ehsan, Mario Torso and Helena Mistry, PhD will be attending throughout. Look forward to meeting colleagues, partners and collaborators. The scientific sessions always deliver and updates on key drug trials will no doubt capture everyones attention. We are presenting our posters on some hot (🔥) topics and we cannot wait to showcase the results with you all at the right time. Huge thanks to our collaborators. Below are the titles. 30th July Poster no. 481, Impact of TDP-43 co-pathology on limbic cortical microstructure in Alzheimer's disease: evidence from an autopsy-confirmed cohort with in-vivo diffusion MRI. 31st July Poster no. 392, Detection of presymptomatic cerebral amyloid angiopathy, CAA, using diffusion MRI analysis of cortical grey matter in hereditary mutation carriers. See you all there. #ENDALZ, #Dementia #Alzheimersdisease #MRI #Scientificresearch #cortex #microstructure

Changes in #brainstructure and more precisely the #microstructure is essential in any #neuromodulation therapy. Using world leading measures of #neurodegeneration like CDM, combined with pioneering method from world class collaborators at Fondazione Santa Lucia (Giacomo Koch), Harvard Medical School & Mass General Brigham (Emiliano Santarnecchi), you produce some amazing work and pave the way to really helping #alzheimer patients around the world. A huge thank you to all the authors. We are proud of our partnership here and look forward to continuing to support this intervention right through to regulatory approval. 😊 🇮🇹 🇬🇧 🇺🇸 Our new paper "Macro and micro structural preservation of grey matter integrity after 24 weeks of rTMS in Alzheimer’s disease patients: a pilot study" is now available online via the link below. https://lnkd.in/gDAP56w4 Sinaptica Therapeutics #rTMS #innovation #neurodegeneration #alzheimersdisease #cortex #precunus #MRI #Diffusion #Dementia #noninvasive #neuroplasticity

Today we are really pleased to announce our collaboration with SimonMed Imaging. A huge thanks to Dr David Lefkowitz and Dr John Simon for all their support to put this #collaboration together. Cannot wait to see the insights from this alliance. We continue to charge ahead with seeking out partners and collaborators in the #USA. Establishing this partnership will enable further insights into discovering the important role #cortical #microstructure will play in a clinical setting with access to standard #MRI. For more details check out the press release link below. https://lnkd.in/dMUWpKYC #radiology #MRI #diffusion #dementia #alzheimerdisease

A huge thank you to the The Michael J. Fox Foundation for Parkinson's Research for organising the #MRI Biomarkers workshop last week in #NewYork. The event was amazing, packed with #pioneering research and innovation in #Parkinsons. Our very own Dr Steven Chance was invited to speak and present our work in PD. Want to find out more about CDM in PD, reach out to us! #neurodegeneration #cortex #biomarkers #imaging #MRI

That’s a wrap for #ASNR24. An amazing conference and location. Valuable insights into the challenges and opportunities that #neuroradiologists face. #MRI plays a critical role in everthing they do. Some key themes coming out for #alzheimers like improved #diagnosis, #ARIA, dynamics in treatment regimes and serving patients better. Look forward to next years event. Viva #lasvegas! #dementia #mri #neurodegeneration #radiology

We are really excited to be attending #ASNR24, our CEO & Co-Founder Dr Steven Chance and Chief Commercial officer Omar Ehsan will attending in Las Vegas. Our abstract was accpeted for presentation. Come and join us during our talk. We would love to hear from everyone in the #neuroradiology community. The title of our talk is "Correspondence Between Automatic Micro and Macrostructural MRI Assessment and Medial Temporal Atrophy Visual Rating Scale". #mri #neurodegeneration #microstructure #cortex #dementia #alzheimers

Happy #mayday to everyone in our beautiful city of #oxford. We wish every one a safe, happy and joyful day as the folks continue a 500 year old tradition. The Magdalen College choir sang Hymnus Eucharisticus from the college's Great Tower as part of the traditional ceremony. #enjoy #dance #music.

OBN (UK) Ltd is hosting its 18th edition of #BioTrinity – a must-attend conference for the life sciences industry. They aim to bring together innovative R&D companies, academia, investors, and pharma companies to facilitate investment in the UK’s most exciting life sciences technology, all under one roof. BioTrinity 2024, will take place on 23-24 April at Convene, 133 Houndsditch, London. Dr Steven Chance will be attending and presenting Oxford Brain Diagnostics Ltd and will be accompanied by our COO Terry Pollard. #dementia #startup #alzheimers #neurodegeneration Find out more at www.biotrinity.com 

#AAN.. Dr Steven Chance and Omar Ehsan attending AAN2024. Fantastic event so far and making new connections and meeting the global #neurologist community. Fascinating insights into #alzheimerdisease and the efforts being put into clinical pathways and education material in readiness for the anti amyloid treatments. Awesome to witness the continued utility of #MRI in this new era. Big shout out to #Denver.